Filana Therapeutics, Inc. (FLNA) Tops Q2 EPS by 3c

Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q2 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA says CTA Treasury shorts stable, euro short-cover risk rises